– Received FDA approval of CGuard® Prime for Transcarotid Arterial Revascularization (TCAR) procedures, expected to approximately double the U.S. addressable market – – Company to host investor conference call today, November 12th, at 4:30pm ET – MIAMI, Nov. 12, 2026 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® […]
Category Archives: Globe Newswire
MIAMI, Nov. 12, 2026 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that it has commenced a proposed public offering of (i) shares of its common stock, (ii) in lieu of common stock to certain investors, pre-funded […]
The methanol market is driven by expanding petrochemical capacity across China, the United States, and emerging Asian economies, the marine sector’s shift toward low-carbon fuels and growing adoption of green methanol, increasing use of methanol-to-olefins (MTO) routes, the expansion of waste-to-methanol projects using municipal solid waste (MSW) gasification, and rising e-methanol demand supported by CO₂-utilization […]
Hearing request stays any suspension or delisting action; ordinary shares continue to trade on the Nasdaq Capital Market pending the Hearings Panel’s decision TEL AVIV, Israel, Nov. 12, 2026 (GLOBE NEWSWIRE) — PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”) today announced that on November 9, 2026, it received a letter from the Listing […]
FDA agrees to provide written guidance by January 4, 2027, to support development of YDB-LMSCEV-001 TAIPEI, Taiwan, Nov. 12, 2026 (GLOBE NEWSWIRE) — YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection and ophthalmologic innovations, today announced that the U.S. Food and Drug Administration (the “FDA”) […]
– Approval doubles the CGuard Prime platform’s total addressable market in the U.S. with additional access to over 35,000 TCAR procedures annually – – Approval supported by CGUARDIANS II pivotal trial data, which demonstrated 100% acute device success and zero death, stroke, myocardial infarction or stent thrombosis reported at 30 days – MIAMI, Nov. 12, […]
KUALA LUMPUR, MALAYSIA, Nov. 12, 2026 (GLOBE NEWSWIRE) — Bio Green Med Solution, Inc. (NASDAQ: BGMS; “BGMS” or the “Company”), a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today announced third quarter financial results and provided a business update. Highlights of the third quarter ended September 30, 2026, […]
The cosmetic peptide synthesis market is projected to register a CAGR of 5.34% from 2027 to 2032, with Asia-Pacific emerging as the fastest-growing regional market. Hyderabad, India, Nov. 12, 2026 (GLOBE NEWSWIRE) — The global cosmetic peptide synthesis market is projected to grow from USD 260.20 million in 2026 and USD 274 million in 2027 to […]
The transactional email API accepts Resend SDK requests unchanged, gives 5,000 free emails a month, and its open-source agent-email-guard cut a 400-email runaway agent loop to 3 in a published benchmark. Dubai, United Arab Emirates, Nov. 12, 2026 (GLOBE NEWSWIRE) — AgentiSend, a Resend alternative for teams that send password resets, receipts, alerts and sign-in […]
The BCMA targeted therapies competitive landscape report delivers important insights into approved as well as ongoing research on 100+ pipeline BCMA targeted therapies, clinical strategies, upcoming therapeutics, and commercial analysis. New York, USA, Nov. 12, 2026 (GLOBE NEWSWIRE) — BCMA Targeted Therapies Competitive Landscape Analysis: 100+ Pipeline Therapies Driving Innovation in Therapeutics Segment | DelveInsight […]

